Market Place
Sourcing Support
Seer to Attend Morgan Stanley Global Healthcare Conference
26 Aug 2025 //
GLOBENEWSWIRE
Seer Joins Canaccord Genuity 45th Annual Growth Conference
31 Jul 2025 //
GLOBENEWSWIRE
Seer to Report Q2 2025 Financial Results on August 6
22 Jul 2025 //
GLOBENEWSWIRE
Seer, Korea Univ Run 20K-Sample Study For Cancer Diagnosis
01 Jun 2025 //
GLOBENEWSWIRE
Seer Launches New Proteograph Workflow at ASMS 2025
29 May 2025 //
GLOBENEWSWIRE
Seer Reports Q1 2025 Results, Reiterates Full Year Outlook
13 May 2025 //
GLOBENEWSWIRE
Seer to Report Q1 2025 Financial Results on May 13, 2025
24 Apr 2025 //
GLOBENEWSWIRE
Seer To Join TD Cowen 45th Annual Health Care Conference
21 Feb 2025 //
GLOBENEWSWIRE
Seer Showcases Proteomic Advances In Cancer & RNA Therapy
20 Feb 2025 //
GLOBENEWSWIRE
Seer to Report Q4 & Full Year 2024 Financial Results on Feb 27,
13 Feb 2025 //
GLOBENEWSWIRE
Seer to Present at J.P. Morgan 43rd Annual Healthcare Conference
02 Jan 2025 //
GLOBENEWSWIRE
Seer Ranked #57 Fastest-Growing on 2024 Deloitte Fast 500™
21 Nov 2024 //
GLOBENEWSWIRE
Seer to Participate in Upcoming November Investor Conferences
08 Nov 2024 //
GLOBENEWSWIRE
Seer Signs Co-Marketing Agreement with Thermo Fisher
06 Nov 2024 //
GLOBENEWSWIRE
Seer Reports Q3 2024 Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
Seer Showcases Deep Proteomics for Alzheimer’s, Lung Cancer at ASHG
31 Oct 2024 //
GLOBENEWSWIRE
Seer Showcases Proteomic Advancements At HUPO 2024
21 Oct 2024 //
GLOBENEWSWIRE
Seer To Report Q3 2024 Financial Results On November 6
17 Oct 2024 //
GLOBENEWSWIRE
Seer to Participate in the Morgan Stanley 22nd Global Healthcare Conference
22 Aug 2024 //
GLOBENEWSWIRE
Seer Appoints Nicolas Roelofs to its Board of Directors
14 Aug 2024 //
GLOBENEWSWIRE
Seer Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Seer Proteograph™ Provides Insights into Spaceflight Proteomic Alterations
11 Jun 2024 //
GLOBENEWSWIRE
Seer Enables Unprecedented Scale For PrognomiQ`s Early Cancer Detection
02 Jun 2024 //
GLOBENEWSWIRE
Seer European Tech Access Center For Proteomics Solutions
08 May 2024 //
GLOBENEWSWIRE
Seer Reports First Quarter 2024 Financial Results
08 May 2024 //
GLOBENEWSWIRE
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
23 Apr 2024 //
GLOBENEWSWIRE
Seer Reports Fourth Quarter and Full Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
21 Feb 2024 //
GLOBENEWSWIRE
Seer Proteograph Enables Unprecedented Genetic Marker Mapping
06 Feb 2024 //
GLOBENEWSWIRE
Seer to Report Fourth Quarter and Full Year 2023 Financial Results
01 Feb 2024 //
GLOBENEWSWIRE
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
21 Dec 2023 //
GLOBENEWSWIRE
Seer to Present at the Canaccord MedTech
10 Nov 2023 //
GLOBENEWSWIRE
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough
08 Nov 2023 //
GLOBENEWSWIRE
Seer Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
01 Nov 2023 //
GLOBENEWSWIRE
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
19 Oct 2023 //
GLOBENEWSWIRE
Seer to Participate in Upcoming September Investor Conferences
08 Sep 2023 //
GLOBENEWSWIRE
Seer Reports Second Quarter 2023 Financial Results
08 Aug 2023 //
GLOBENEWSWIRE
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
27 Jul 2023 //
GLOBENEWSWIRE
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
13 Jul 2023 //
GLOBENEWSWIRE
Seer Collaborates to Make Proteomics Accessible to More Researchers
07 Jun 2023 //
GLOBENEWSWIRE
Seer Launches the Proteograph XT Assay Kit
01 Jun 2023 //
GLOBENEWSWIRE
Seer Reports First Quarter 2023 Financial Results
09 May 2023 //
GLOBENEWSWIRE
Seer to Report First Quarter 2023 Financial Results on May 9, 2023
20 Apr 2023 //
GLOBENEWSWIRE
Seer Proteograph Product Suite identifies undiscovered links between protein variants and lung cancer progression
29 Mar 2023 //
GLOBENEWSWIRE
Seer Reports Fourth Quarter and Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Seer to Present at the Cowen 43rd Annual Health Care Conference
21 Feb 2023 //
GLOBENEWSWIRE
Seer to Report Q4 and Full Year 2022 Financial Results on March 2, 2023
09 Feb 2023 //
GLOBENEWSWIRE
Seer to Present at the J.P. Morgan 41st Annual Health Care Conference
27 Dec 2022 //
GLOBENEWSWIRE
Seer’s Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist
12 Dec 2022 //
GLOBENEWSWIRE
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
13 Oct 2022 //
GLOBENEWSWIRE
FDA clears Seer Medical’s at-home epilepsy monitoring system
26 Sep 2022 //
FIERCEBIOTECH
Seer Announces Publication of Power of Engineered Nano-Bio Interactions studies
23 Aug 2022 //
GLOBENEWSWIRE
Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript
10 Aug 2022 //
FOOL
Seer Launches First-of-its-kind Proteogenomics Workflow
03 Aug 2022 //
GLOBENEWSWIRE
Seer to Report Second Quarter 2022 Financial Results on August 9, 2022
14 Jul 2022 //
GLOBENEWSWIRE
Seer Reports First Quarter 2022 Financial Results
04 May 2022 //
GLOBENEWSWIRE
Seer to Present at the BofA Securities 2022 Healthcare Conference
28 Apr 2022 //
GLOBENEWSWIRE
Seer to Report First Quarter Financial Results on May 4, 2022
07 Apr 2022 //
GLOBENEWSWIRE
Seer says Appointment of Scott D. Thomas as Chief Commercial Officer
16 Mar 2022 //
GLOBENEWSWIRE
